文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

入侵性口蹄疫病毒血清型 SAT2 的 B 和 T 细胞表位,用于疫苗开发。

B and T Cell Epitopes of the Incursionary Foot-and-Mouth Disease Virus Serotype SAT2 for Vaccine Development.

机构信息

Key Laboratory of Veterinary Etiological Biology, National/WOAH Foot and Mouth Disease Reference Laboratory, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.

Department of Veterinary Basics and Diagnostic Sciences, College of Veterinary Science, Mekelle University, Mekelle 2084, Tigray, Ethiopia.

出版信息

Viruses. 2023 Mar 21;15(3):797. doi: 10.3390/v15030797.


DOI:10.3390/v15030797
PMID:36992505
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10059872/
Abstract

Failure of cross-protection among interserotypes and intratypes of foot-and-mouth disease virus (FMDV) is a big threat to endemic countries and their prevention and control strategies. However, insights into practices relating to the development of a multi-epitope vaccine appear as a best alternative approach to alleviate the cross-protection-associated problems. In order to facilitate the development of such a vaccine design approach, identification and prediction of the antigenic B and T cell epitopes along with determining the level of immunogenicity are essential bioinformatics steps. These steps are well applied in Eurasian serotypes, but very rare in South African Territories (SAT) Types, particularly in serotype SAT2. For this reason, the available scattered immunogenic information on SAT2 epitopes needs to be organized and clearly understood. Therefore, in this review, we compiled relevant bioinformatic reports about B and T cell epitopes of the incursionary SAT2 FMDV and the promising experimental demonstrations of such designed and developed vaccines against this serotype.

摘要

不同血清型和同型之间的口蹄疫病毒(FMDV)交叉保护失败是地方性流行国家及其防控策略的一大威胁。然而,深入了解多表位疫苗的开发实践似乎是缓解交叉保护相关问题的最佳替代方法。为了促进这种疫苗设计方法的发展,鉴定和预测抗原 B 和 T 细胞表位以及确定免疫原性水平是必要的生物信息学步骤。这些步骤在欧亚血清型中得到了很好的应用,但在南非领土(SAT)类型中非常罕见,特别是在血清型 SAT2 中。出于这个原因,需要对 SAT2 表位的现有分散的免疫信息进行组织和清晰的理解。因此,在这篇综述中,我们汇编了关于入侵性 SAT2 FMDV 的 B 和 T 细胞表位的相关生物信息学报告,以及针对这种血清型设计和开发的疫苗的有前途的实验证明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0d/10059872/a7ee38001c96/viruses-15-00797-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0d/10059872/41e17b936505/viruses-15-00797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0d/10059872/c74677270d58/viruses-15-00797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0d/10059872/7c2e3fc9ba16/viruses-15-00797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0d/10059872/a7ee38001c96/viruses-15-00797-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0d/10059872/41e17b936505/viruses-15-00797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0d/10059872/c74677270d58/viruses-15-00797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0d/10059872/7c2e3fc9ba16/viruses-15-00797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0d/10059872/a7ee38001c96/viruses-15-00797-g004.jpg

相似文献

[1]
B and T Cell Epitopes of the Incursionary Foot-and-Mouth Disease Virus Serotype SAT2 for Vaccine Development.

Viruses. 2023-3-21

[2]
Chimeric Porcine Parvovirus VP2 Virus-like Particles with Epitopes of South African Serotype 2 Foot-and-Mouth Disease Virus Elicits Specific Humoral and Cellular Responses in Mice.

Viruses. 2024-4-17

[3]
Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.

Vaccine. 2015-6-9

[4]
Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.

Virol J. 2019-12-16

[5]
Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.

Mol Immunol. 2020-3-18

[6]
Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.

Virol J. 2012-3-14

[7]
Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate.

Sci Rep. 2018-9-12

[8]
Co-expression of the Bcl-xL antiapoptotic protein enhances the induction of Th1-like immune responses in mice immunized with DNA vaccines encoding FMDV B and T cell epitopes.

Vet Res Commun. 2013-3-13

[9]
Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.

J Gen Virol. 2010-12-22

[10]
Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.

J Med Virol. 2019-8-24

引用本文的文献

[1]
Preliminary evaluation of a novel serotype O foot-and-mouth disease mRNA vaccine.

Front Microbiol. 2025-4-28

[2]
Design and application of expression constructs for FMDV serotype O structural proteins.

Biotechnol Lett. 2025-4-21

[3]
Foot-and-mouth disease: genomic and proteomic structure, antigenic sites, serotype relationships, immune evasion, recent vaccine development strategies, and future perspectives.

Vet Res. 2025-4-7

[4]
T-Cell Epitope-Based Vaccines: A Promising Strategy for Prevention of Infectious Diseases.

Vaccines (Basel). 2024-10-17

[5]
Protein characterization of an Indonesian isolate of foot and mouth disease virus inactivated with formaldehyde and binary ethylenimine.

Vet World. 2024-8

[6]
Cell Culture Adaptive Amino Acid Substitutions in FMDV Structural Proteins: A Key Mechanism for Altered Receptor Tropism.

Viruses. 2024-3-27

[7]
Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface.

Vaccines (Basel). 2023-9-14

本文引用的文献

[1]
Development of Foot-and-Mouth Disease Vaccines in Recent Years.

Vaccines (Basel). 2022-10-28

[2]
Biodegradable Imiquimod-Loaded Mesoporous Organosilica as a Nanocarrier and Adjuvant for Enhanced and Prolonged Immunity against Foot-and-Mouth Disease Virus in Mice.

ACS Appl Bio Mater. 2022-6-20

[3]
Phage T7 as a Potential Platform for Vaccine Development.

Methods Mol Biol. 2022

[4]
Foot and Mouth Disease Vaccine Development and Challenges in Inducing Long-Lasting Immunity: Trends and Current Perspectives.

Vet Med (Auckl). 2021-9-1

[5]
Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health.

Vaccines (Basel). 2021-5-8

[6]
Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants.

Res Vet Sci. 2021-5

[7]
Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs.

BMC Vet Res. 2020-12-4

[8]
Promotion of Cellular and Humoral Immunity against Foot-and-Mouth Disease Virus by Immunization with Virus-Like Particles Encapsulated in Monophosphoryl Lipid A and Liposomes.

Vaccines (Basel). 2020-10-31

[9]
A novel multiple emulsion enhanced immunity its biomimetic delivery approach.

J Mater Chem B. 2020-8-26

[10]
Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses.

Vaccines (Basel). 2020-5-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索